{"id":20712,"date":"2021-10-07T12:56:53","date_gmt":"2021-10-07T10:56:53","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=20712"},"modified":"2021-10-07T12:56:53","modified_gmt":"2021-10-07T10:56:53","slug":"dideles-rizikos-salyti-tureje-vakcinuoti-ar-covid-19-persirge-asmenys-gali-issitirti-nemokamai","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/en\/2021\/10\/07\/dideles-rizikos-salyti-tureje-vakcinuoti-ar-covid-19-persirge-asmenys-gali-issitirti-nemokamai\/","title":{"rendered":"Didel\u0117s rizikos s\u0105lyt\u012f tur\u0117j\u0119 vakcinuoti ar COVID-19 persirg\u0119 asmenys gali i\u0161sitirti nemokamai"},"content":{"rendered":"<p><strong>Nors pagal piln\u0105 vakcinacijos schem\u0105 pasiskiepijusi\u0173 ir COVID-19 liga persirgusi\u0173j\u0173 asmen\u0173 tikimyb\u0117 u\u017esikr\u0117sti \u0161ia liga yra gerokai ma\u017eesn\u0117, ta\u010diau ji i\u0161lieka. Tod\u0117l tur\u0117jus didel\u0117s rizikos s\u0105lyt\u012f, svarbu imtis papildom\u0173 atsargumo priemoni\u0173: rekomenduojama ne tik vengti susib\u016brim\u0173, bet ir objektyviai \u012fvertinus tur\u0117t\u0105 rizik\u0105 ne anks\u010diau kaip 3 dien\u0105 po tur\u0117to kontakto atlikti test\u0105. PGR tyrimas arba greitasis antigeno testas tokiems asmenims mobiliuose punktuose atliekami nemokamai, valstyb\u0117s l\u0117\u0161omis.<\/strong><\/p>\n<p><strong><img data-recalc-dims=\"1\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/sam.lrv.lt\/uploads\/sam\/documents\/images\/Didel%C4%97s%20rizikos%20s%C4%85lyt%C4%AF%20tur%C4%97j%C4%99%20vakcinuoti%20ar%20COVID-19%20persirg%C4%99%20asmenys%20gali%20i%C5%A1sitirti%20nemokamai%20%281%29.png?w=1200&#038;ssl=1\" alt=\"\" \/><\/strong><\/p>\n<p>Registruotis tyrimui galima internetu, pasirenkant mygtuk\u0105 \u201eVakcinuotiems ar persirgusiems didel\u0117s rizikos s\u0105lyt\u012f su sergan\u010diuoju COVID-19 liga tur\u0117jusiems asmenims, kuriems netaikoma izoliacija\u201c arba paskambinus numeriu 1808.<\/p>\n<p>Taigi, jei pagal piln\u0105 skiepijimo schem\u0105 vakcinuotas arba persirg\u0119s asmuo tur\u0117jo didel\u0117s rizikos s\u0105lyt\u012f, jis:<\/p>\n<p>1.\u00a0Neturi izoliuotis. Dirban\u010diam asmeniui rekomenduojama tik nuvykti \u012f darb\u0105 ir namus, jei n\u0117ra galimyb\u0117s dirbti nuotoliniu b\u016bdu. Jis netur\u0117t\u0173 dalyvauti renginiuose, kitose \u017emoni\u0173 susib\u016brimo vietose, turi apriboti asmen\u0173, su kuriais bendraujama, skai\u010di\u0173. Bendraujant su kitais asmenimis, tokie asmenys turi d\u0117v\u0117ti nos\u012f ir burn\u0105 dengian\u010dias apsaugos priemones, laikytis saugaus atstumo ir kit\u0173 bendr\u0173j\u0173 COVID-19 ligos prevencijos priemoni\u0173.<\/p>\n<p>2. Rekomenduojama ne anks\u010diau kaip 3 dien\u0105 po tur\u0117to kontakto atlikti PGR tyrim\u0105 arba greit\u0105j\u012f antigeno test\u0105. Tyrimo atlikti nereikia asmenims, kurie persirgo COVID-19 liga ma\u017eiau nei prie\u0161 90 dien\u0173.<\/p>\n<p>3. Turi steb\u0117ti savo sveikatos b\u016bkl\u0119. Jei s\u0105lyt\u012f tur\u0117jusiam asmeniui pasirei\u0161kia COVID-19 ligai b\u016bdingi simptomai, jis nedelsiant turi izoliuotis, registruotis tyrimui ir kreiptis \u012f savo \u0161eimos gydytoj\u0105.<\/p>\n<p>Vakcina nuo COVID-19 neapsaugo nuo \u0161ios ligos \u0161imtu procent\u0173, ta\u010diau tai yra \u0161iuo metu pati veiksmingiausia priemon\u0117, siekiant i\u0161vengti sunki\u0173 komplikacij\u0173 ar net mirties. Kaip parod\u0117 Lietuvos statistikos departamento vykdoma vakcin\u0173 veiksmingumo bei galim\u0173 \u0161alutini\u0173 poveiki\u0173 steb\u0117sena Lietuvoje, pasiskiepijusi\u0173 asmen\u0173 rizika u\u017esikr\u0117sti suma\u017e\u0117ja net 5 kartus, rizika patekti \u012f ligonin\u0119 d\u0117l COVID-19 yra 10 kart\u0173 ma\u017eesn\u0117 nei nepasiskiepijusi\u0173j\u0173, rizika numirti nuo COVID-19 \u2013 bent 20 kart\u0173 ma\u017eesn\u0117. Pirmojoje j\u0173 teiktos ataskaitos dalyje pateikti duomenys apie gamintojo \u201ePfizer-BioNTech\u201c vakcinos \u201eComirnaty\u201c efektyvum\u0105 apsaugant nuo u\u017esikr\u0117timo Delta atmaina, hospitalizacijos ir mirties.<\/p>\n<p><em><a href=\"https:\/\/sam.lrv.lt\/lt\/kontaktai-ziniasklaidai\">SAM Spaudos tarnyba<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Nors pagal piln\u0105 vakcinacijos schem\u0105 pasiskiepijusi\u0173 ir COVID-19 liga persirgusi\u0173j\u0173 asmen\u0173 tikimyb\u0117 u\u017esikr\u0117sti \u0161ia liga yra gerokai ma\u017eesn\u0117, ta\u010diau ji i\u0161lieka. Tod\u0117l tur\u0117jus didel\u0117s rizikos s\u0105lyt\u012f, svarbu imtis papildom\u0173 atsargumo priemoni\u0173: rekomenduojama ne tik vengti susib\u016brim\u0173, bet ir objektyviai \u012fvertinus tur\u0117t\u0105 rizik\u0105 ne anks\u010diau kaip 3 dien\u0105 po tur\u0117to kontakto atlikti test\u0105. PGR tyrimas arba&hellip;<\/p>","protected":false},"author":5,"featured_media":20713,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-20712","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-5o4","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2021\/10\/19471_ca109ae20009257d2cdd98ba4c5ba849.png","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/20712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/comments?post=20712"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/20712\/revisions"}],"predecessor-version":[{"id":20714,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/20712\/revisions\/20714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media\/20713"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media?parent=20712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/categories?post=20712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/tags?post=20712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}